VG Life Sciences Inc. (VGLS)

[jurisper]

Anyway, it makes it more interesting than the common penny pump'n'dump with just an empty shell. A nexus of scumbags plus some real scientists and biz people ... mix 'em together and what do you get?

That's a nice announcement today for the science. It's very early clinical work - Phase I safety study with some secondary efficacy targets. I think the success rate from this point to a commercial drug is generally about 5% (requiring years and $ millions).

But the approach seems sensible - I guess if it can be shown that Newell's IP safely enhances efficacy of exitsing drugs then there will be a reason for pharma companies to be interested in it, possibility of accelerated route to market.

Would be nice to see it in the hands of something with corporate credibility.